Actively Recruiting
Feasibility and Safety Evaluation of the Axonics External Trial System for Overactive Bladder and Fecal Incontinence
Led by Axonics, Inc. · Updated on 2026-10-13
75
Participants Needed
5
Research Sites
4 weeks
Total Duration
AI-Summary
What This Trial Is About
This research aims to evaluate the feasibility and safety of the new Axonics External Trial System ETS-02 in patients with overactive bladder OAB andor fecal incontinence FI. It focuses on determining if patients respond to sacral neuromodulation SNM before receiving the Axonics implantable neurostimulator INS, which is approved for treating OAB and FI. Participants will use the Axonics External Trial System, which involves placing a temporary electrode wire through the S3 foramen, sometimes with imaging guidance. This wire connects to an external pulse generator worn for a trial period of 3 to 7 days to assess responsiveness to SNM. During the study, participants will be monitored for overall feasibility between days 5 and 7 and for any adverse events from the start through day 7. Assessments include bladder or bowel diaries, safety monitoring, and compliance with study visits. The total participation period covers the trial duration and follow-up for safety outcomes.
CONDITIONS
Brief Title
Aquarius Pilot Study to Evaluate the New Axonics Trial System
Research Team
E
Erum Shaikh
G
Gita Ghadimi, OD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here